VEGFA and colorectal carcinoma: Besides combining afatinib with standard chemotherapy and/or radiotherapy, combinations with other targeted agents such as vascular endothelial growth factor inhibitors have been investigated in clinical studies, with limited success in CRC patients [57,58].